Grünenthal GmbH

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40012354

Informations générales

Localisation

Germany

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

07/08/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

Near-Term Targets: Grünethal GmbH commits to reduce absolute scope 1 and 2 GHG emissions 55% by 2030 from a 2020 base year. Grünethal GmbH also commits that 74.1% of its suppliers by emissions covering purchased goods and services and upstream transportation and distribution will have science-based targets by 2028.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

XS2615562274

LEI

529900SH895E31PGLA72

Source : Science Based Targets initiative | Données publiques